Document is current
Any future updates will be listed below
-
Authors
Boada, L. https://orcid.org/0000-0003-4518-5208
Lahera, G.
Pina-Camacho, L.
Merchán-Naranjo, J.
Díaz-Caneja, C. M.
Bellón, J. M.
Ruiz-Vargas, J. M.
Parellada, M.
- License Information
-
More Information
Article History
First Online: 8 July 2020
Compliance with Ethical Standards
:
: The authors have neither financial relationships nor conflicts of interest relevant to this article to disclose. Lahera has been a consultant to or has received honoraria or grants from Janssen-Cilag, Otsuka-Lundbeck, Lilly, Astra-Zeneca, CIBERSAM and Instituto de Salud Carlos III Pina-Camacho, L. and Diaz-Caneja, CM have received grants from Instituto de Salud Carlos III, Spanish Ministry of Science, Innovation and Universities, and from Fundación Alicia Koplowitz. Mara Parellada has been consultant for Foundation Alicia Koplowitz, Servier and Instituto de Salud Carlos III (ISCIII), Ministry of Health, Madrid, Spain, has received grant support from ISCIII, Horizon2020 of the European Union, Fundación Mutua Madrileña, Fundación Orange, CIBERSAM, has received educational support from Otsuka and Janssen Cilag and has participated in Clinical Trials with the economic support of Horizon 2020, Roche and Servier.
